Group One Trading, L.P. Lipocine Inc. Transaction History

Group One Trading, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.3 - $0.58 $613 - $1,186	2,046 New	2,046 $0
Q2 2021 Aug 10, 2021	SELL	$1.17 - $1.59 $60,704 - $82,495	-51,884 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$1.38 - $2.28 $71,599 - $118,295	51,884 New	51,884 $78,000
Q3 2020 Nov 12, 2020	SELL	$1.21 - $2.23 $45,434 - $83,734	-37,549 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.42 - $1.26 $2,016 - $6,048	4,800 Added 14.66%	37,549 $47,000
Q1 2020 May 13, 2020	SELL	$0.32 - $0.77 $8,181 - $19,687	-25,568 Reduced 43.84%	32,749 $16,000
Q4 2019 Feb 10, 2020	BUY	$0.32 - $3.15 $17,183 - $169,151	53,699 Added 1162.82%	58,317 $22,000
Q3 2019 Nov 12, 2019	SELL	$1.79 - $3.33 $17,044 - $31,708	-9,522 Reduced 67.34%	4,618 $13,000
Q1 2019 May 13, 2019	SELL	$1.46 - $2.33 $8,079 - $12,894	-5,534 Reduced 28.13%	14,140 $33,000
Q4 2018 Feb 06, 2019	SELL	$1.07 - $1.63 $4,280 - $6,520	-4,000 Reduced 16.9%	19,674 $26,000
Q3 2018 Nov 08, 2018	SELL	$1.31 - $1.63 $57,349 - $71,358	-43,778 Reduced 64.9%	23,674 $33,000
Q2 2018 Aug 14, 2018	BUY	$1.06 - $1.78 $3,837 - $6,443	3,620 Added 5.67%	67,452 $88,000
Q1 2018 May 11, 2018	BUY	$1.18 - $3.46 $75,321 - $220,858	63,832 New	63,832 $98,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $415M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.